Anuh Pharma

28
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE489G01022
  • NSEID: ANUHPHR
  • BSEID: 506260
INR
73.18
-0.7 (-0.95%)
BSENSE

Jan 19

BSE+NSE Vol: 21.4 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 2.24% vs 22.66% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -18.77% vs 46.23% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 29.81% vs 28.25% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -21.16% vs 66.00% in Mar 2024

Compare Profit and Loss Results of Anuh Pharma
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
661.00
599.00
62.00
10.35%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
661.00
599.00
62.00
10.35%
Expenditure (Ex Depriciation)
Stock Adjustments
-2.00
1.00
-3.00
-300.00%
Raw Materials Consumed
501.00
292.00
209.00
71.58%
Power & Fuel Cost
12.00
24.00
-12.00
-50.00%
Employee Cost
23.00
104.00
-81.00
-77.88%
Operating Expenses
28.00
12.00
16.00
133.33%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
10.00
33.00
-23.00
-69.70%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
19.00
21.00
-2.00
-9.52%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
599.00
523.00
76.00
14.53%
Operating Profit (PBDIT) excl Other Income
61.00
76.00
-15.00
-19.74%
Other Income
9.00
3.00
6.00
200.00%
Operating Profit (PBDIT)
70.00
79.00
-9.00
-11.39%
Interest
1.00
36.00
-35.00
-97.22%
Profit before Depriciation and Tax
69.00
42.00
27.00
64.29%
Depreciation
8.00
13.00
-5.00
-38.46%
Profit Before Taxation & Exceptional Items
61.00
29.00
32.00
110.34%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
61.00
29.00
32.00
110.34%
Provision for Tax
13.00
0.00
13.00
0%
Profit After Tax
47.00
30.00
17.00
56.67%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
156.00
-138.00
294.00
213.04%
Profit Available for appropriations
203.00
-107.00
310.00
289.72%
Appropriations
203.00
-107.00
310.00
289.72%
Equity Dividend (%)
30%
0%
30.00
Earnings Per Share
9.45
9.32
0.13
1.39%
Profit And Loss - Net Sales
Net Sales 661.51 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 2.24% vs 22.66% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 61.53 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -18.77% vs 46.23% in Mar 2024

Profit And Loss - Interest
Interest 1.24 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 29.81% vs 28.25% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 47.35 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -21.16% vs 66.00% in Mar 2024